Enroquin™ Flavored Tablets (enrofloxacin)

INDICATIONS: Enroquin Flavored Tablets (enrofloxacin) are indicated for the management of diseases associated with bacteria susceptible to enrofloxacin.  Enroquin Flavored Tablets are indicated for use in dogs and cats.

Indications:

• Dermal Infections: Enroquin concentrates in inflamed tissues resulting in high drug levels at the infection site.
• Respiratory Tract Infections: Enroquin achieves therapeutic concentrations in pulmonary and bronchial tissues. Enrofloxacin irreversibly inhibits a bacterial enzyme resulting in rapid bactericidal action.
• Urinary Tract Infections: Enroquin provides rapid bactericidal action in the urinary tract and is indicated for the effective management of acute or chronic infections of the genito-urinary tract and prostate.

Dosage and Administration:
Dogs: Administer orally at a rate to provide 5-20 mg/kg (2.27 to 9.07 mg/lb) of body weight. Selection of a dose within the range should be based on clinical experience, the severity of disease, and susceptibility of the pathogen. Animals which receive doses in the upper-end of the dose range should be carefully monitored for clinical signs that may include inappetence, depression, and vomition. If dogs do not consume Enroquin Flavored Tablets willingly when offered by hand, then alternatively the tablet(s) may be offered in the food or hand-administered (pilled) as with other oral tablet medications.

Cats: Administer orally at 5 mg/kg (2.27 mg/lb) of body weight. The dose for dogs and cats may be administered either as a single daily dose or divided into two (2) equal daily doses administered at twelve (12) hour intervals. The dose should be continued for at least 2-3 days beyond cessation of clinical signs, to a maximum of 30 days. In cats, Enroquin Flavored Tablets should be pilled. After administration, watch the animal closely to be certain the entire dose has been consumed.